Status:
WITHDRAWN
Can Blood Panels Provide Early Warning of Bleeding in Patients on ECMO?
Lead Sponsor:
Montefiore Medical Center
Conditions:
ECMO
Bleeding
Eligibility:
All Genders
18-70 years
Brief Summary
This is a prospective, observational study of 60 adult patients anticoagulated with bivalirudin for extracorporeal membrane oxygenation (ECMO). The study aims to identify the most precise early warnin...
Eligibility Criteria
Inclusion
- adults 18 - 70 years who are anticoagulation (AC) with bivalirudin and placed on ECMO for cardiac and/or respiratory failure. Surgical and non-surgical patients will be included.
Exclusion
- known pre-existing bleeding disorder (due to a factor deficiency that requires factor replacement, or platelet disorder), or a creatinine \> 2.0.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04478136
Start Date
December 1 2021
End Date
June 1 2023
Last Update
April 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.